Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

rs referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About NovartisLocated in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools. Novartis is the only company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.us.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

*Known as Votubia® (everolimus) tablets for this patient population in Switzerland. If approved in the EU for this patient population, the trade name will be Votubia.

# Rapamune® (sirolimus) and Torisel® (temsirolimus) are registered trad
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)...  Australian drug delivery company, Phosphagenics Limited (ASX: POH; ... million via a placement of A$16.3 million to institutional ... Asia and Australia ... plan (SPP) to be offered to existing shareholders.  The ... tranches. "This capital raising positions us strongly ...
(Date:7/11/2014)... 11, 2014 Show ... & Health Expo 2014 were a brand ... London , plus a ...          (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) ... )      (Photo: http://photos.prnewswire.com/prnh/20140711/696892-b ...
(Date:7/10/2014)... Calif. , July 10, 2014  Breg, ... and services, has launched the FreeRunner™ knee brace ... who suffer from patella mal-tracking return to active ... differently than other braces, providing support when patients ... normally when they don,t. Patellofemoral issues ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... Ill., July 28, 2011 The National ... health alert to warn Americans about the serious dangers ... report NABP released today on Internet drug outlets found ... to operate out of compliance with United States pharmacy ...
... Boston Scientific Corporation,s (NYSE: BSX ) Board ... repurchase of up to $1.0 billion of its common ... under an existing share repurchase program. "This ... the Company,s long-term business prospects, earnings growth potential and ...
Cached Medicine Technology:NABP Issues Rogue Online Pharmacy Public Health Alert 2NABP Issues Rogue Online Pharmacy Public Health Alert 3NABP Issues Rogue Online Pharmacy Public Health Alert 4Boston Scientific Announces $1.0B Share Repurchase Program 2Boston Scientific Announces $1.0B Share Repurchase Program 3
(Date:7/11/2014)... July 11, 2014 Operators ... $50 billion in fuel costs now that ... current GHG standards are phasing ... it upon themselves to install new features ... 1.    Idle reduction technologies , 2.    Efficient driveline components ...
(Date:7/11/2014)... 11, 2014 Ticket Down is a ... Pavilion . When it comes to the summer concert schedule, ... 37-year-old Georgia native is one of the biggest names in country ... Bryan is currently out on his “That’s My Kind of Night” ... the tour will be making through the rest of the summer ...
(Date:7/11/2014)... 2014 Global enterprises today are shifting ... day-to-day management activities. Managed services offer these global enterprises ... economic slowdown resulted into rising operational costs to companies. ... considered to be the global market driver for expanding ... global managed services market is estimated to grow from ...
(Date:7/11/2014)... R.I. -- Researchers from The Miriam Hospital ... age 65 have significantly higher rates of smoking ... mobility impairments were less likely to attempt quitting ... treatments may not be sufficient for this population. ... in advance of print in the American ...
(Date:7/11/2014)... to repair damage to the anterior cruciate ligament (ACL) -- ... could increase a young athlete,s risk for further injuries, researchers ... aged 8 to 16, who had ACL reconstruction surgery. Of ... their injury, 37 had surgery six to 12 weeks after, ... their injury. The youngsters who had surgery later had ...
Breaking Medicine News(10 mins):Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:Miriam Hospital study examines smoking prevalence 2Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2
... ... May 15 Meet Cindy Zamirowski, a 56-year-old,breast cancer survivor who less ... stepped off the curb to raise funds for,cancer research in the 5K ... and grandma of three rallied her team of,16 angels at her side ...
... 15 Cleveland Clinic announced today that,the Cleveland ... Reserve,University is providing all its students with full ... Approaching its fifth year in existence, the Cleveland ... training of physician scientists,who are capable of furthering ...
... the Department of Urology have showed that lowering intake of ... prevent prostate cancer in mice, the first finding of its ... researchers said. , The study, which appears in the April ... fat from corn oil, which is made up primarily of ...
... Maxi-K gene therapy may be a safe and effective ... not treatable with oral therapy. Two studies presented today ... Urological Association (AUA) may give hope to these individuals. ... press conference on May 20, 2008 at 10 a.m. ...
... FL, May 20, 2008 Rising global temperatures could ... research presented today at the 103rd Annual Scientific Meeting ... linked to stone disease, particularly in warmer climates, and ... the prevalence of stone disease may increase, along with ...
... 20, 2008 Patients with metabolic syndrome disorders, including ... to develop uric-acid stones than other type of ... 103rd Annual Scientific Meeting of the American Urological ... with uric acid stones could benefit from additional ...
Cached Medicine News:Health News:After Effects: Giving Back Is Good for You 2Health News:Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 2Health News:Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 3Health News:Reducing intake of dietary fat prevents prostate cancer in mice 2Health News:AUA 2008: Maxi-K gene transfer may prove to be safe and effective erectile dysfunction treatment 2Health News:AUA 2008: Uric acid stones may indicate arteriosclerotic diseases 2
Inquire...
Electric Reciprocating Saw, with hand throttle. Can also be purchased without hand throttle (#1915) for use with foot pedal. (#6401-000)...
... without hand throttle, 30,000 RPM, ... medium bur guard included, long ... guards are also available. Must ... (#6401-000), can also be purchased ...
... USA 2001 Universal Battery Charger is manufactured to ... Versipower Plus and 3M MaxiDriver II Battery Packs. ... six Battery Packs simultaneously in less than 40 ... on 120 volt AC grounded electrical power. If ...
Medicine Products: